APO Research

APO RESEARCH · REPORT

DNA Synthesis Service

Selected research

Market Outlook & Growth Opportunities

Global DNA Synthesis Service Market Outlook and Growth Opportunities 2026

Market perspective

The global DNA Synthesis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DNA Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DNA Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DNA Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DNA Synthesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DNA Synthesis Service market include Genescript, Thermo Fisher Scientific, IDT, Eurofins Genomics, DNA 2.0 (ATUM), BBI, Azenta Life Sciences, SBS Genetech and Bio Basic, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global DNA Synthesis Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DNA Synthesis Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA Synthesis Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global DNA Synthesis Service market.

DNA Synthesis Service Segment by Company

Genescript

Thermo Fisher Scientific

IDT

Eurofins Genomics

DNA 2.0 (ATUM)

BBI

Azenta Life Sciences

SBS Genetech

Bio Basic

Twist Bioscience

OriGene

Bioneer

Eton Bioscience

Synbio Technologies

Eurogentec

DNA Synthesis Service Segment by Type

Oligonucleotide Synthesis

Gene Synthesis

DNA Synthesis Service Segment by Application

Commercial

Academic Research

DNA Synthesis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DNA Synthesis Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the DNA Synthesis Service key companies, revenue, market share, and recent developments.

3. To split the DNA Synthesis Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions DNA Synthesis Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DNA Synthesis Service significant trends, drivers, influence factors in global and regions.

6. To analyze DNA Synthesis Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Synthesis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Synthesis Service industry.

Chapter 3: Detailed analysis of DNA Synthesis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of DNA Synthesis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of DNA Synthesis Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DNA Synthesis Service Industry Trends Table 2. DNA Synthesis Service Industry Drivers Table 3. DNA Synthesis Service Industry Opportunities and Challenges Table 4. DNA Synthesis Service Industry Restraints Table 5. Global DNA Synthesis Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DNA Synthesis Service Revenue Share by Company (2021-2026) Table 7. Global DNA Synthesis Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global DNA Synthesis Service Key Company Manufacturing Base & Headquarters Table 9. Global DNA Synthesis Service Company, Product Type & Application Table 10. Global DNA Synthesis Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global DNA Synthesis Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oligonucleotide Synthesis Table 15. Significant Companies of Gene Synthesis Table 16. Global DNA Synthesis Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global DNA Synthesis Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global DNA Synthesis Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global DNA Synthesis Service Sales Value Share by Type (2021-2026) Table 20. Global DNA Synthesis Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Commercial Table 22. Significant Companies of Academic Research Table 23. Global DNA Synthesis Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global DNA Synthesis Service Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global DNA Synthesis Service Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global DNA Synthesis Service Sales Value Share by Application (2021-2026) Table 27. Global DNA Synthesis Service Sales Value Share by Application (2027-2032) Table 28. Global DNA Synthesis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global DNA Synthesis Service Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global DNA Synthesis Service Sales Value Share by Region (2021-2026) Table 31. Global DNA Synthesis Service Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global DNA Synthesis Service Sales Value Share by Region (2027-2032) Table 33. Global DNA Synthesis Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global DNA Synthesis Service Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global DNA Synthesis Service Sales Value Market Share by Country (2021-2026) Table 36. Global DNA Synthesis Service Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global DNA Synthesis Service Sales Value Market Share by Country (2027-2032) Table 38. Genescript Company Information Table 39. Genescript Business Overview Table 40. Genescript DNA Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Genescript DNA Synthesis Service Product Portfolio Table 42. Genescript Recent Development Table 43. Thermo Fisher Scientific Company Information Table 44. Thermo Fisher Scientific Business Overview Table 45. Thermo Fisher Scientific DNA Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Thermo Fisher Scientific DNA Synthesis Service Product Portfolio Table 47. Thermo Fisher Scientific Recent Development Table 48. IDT Company Information Table 49. IDT Business Overview Table 50. IDT DNA Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. IDT DNA Synthesis Service Product Portfolio Table 52. IDT Recent Development Table 53. Eurofins Genomics Company Information Table 54. Eurofins Genomics Business Overview Table 55. Eurofins Genomics DNA Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Eurofins Genomics DNA Synthesis Service Product Portfolio Table 57. Eurofins Genomics Recent Development Table 58. DNA 2.0 (ATUM) Company Information Table 59. DNA 2.0 (ATUM) Business Overview Table 60. DNA 2.0 (ATUM) DNA Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. DNA 2.0 (ATUM) DNA Synthesis Service Product Portfolio Table 62. DNA 2.0 (ATUM) Recent Development Table 63. BBI Company Information Table 64. BBI Business Overview Table 65. BBI DNA Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. BBI DNA Synthesis Service Product Portfolio Table 67. BBI Recent Development Table 68. Azenta Life Sciences Company Information Table 69. Azenta Life Sciences Business Overview Table 70. Azenta Life Sciences DNA Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Azenta Life Sciences DNA Synthesis Service Product Portfolio Table 72. Azenta Life Sciences Recent Development Table 73. SBS Genetech Company Information Table 74. SBS Genetech Business Overview Table 75. SBS Genetech DNA Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. SBS Genetech DNA Synthesis Service Product Portfolio Table 77. SBS Genetech Recent Development Table 78. Bio Basic Company Information Table 79. Bio Basic Business Overview Table 80. Bio Basic DNA Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bio Basic DNA Synthesis Service Product Portfolio Table 82. Bio Basic Recent Development Table 83. Twist Bioscience Company Information Table 84. Twist Bioscience Business Overview Table 85. Twist Bioscience DNA Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Twist Bioscience DNA Synthesis Service Product Portfolio Table 87. Twist Bioscience Recent Development Table 88. OriGene Company Information Table 89. OriGene Business Overview Table 90. OriGene DNA Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. OriGene DNA Synthesis Service Product Portfolio Table 92. OriGene Recent Development Table 93. Bioneer Company Information Table 94. Bioneer Business Overview Table 95. Bioneer DNA Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Bioneer DNA Synthesis Service Product Portfolio Table 97. Bioneer Recent Development Table 98. Eton Bioscience Company Information Table 99. Eton Bioscience Business Overview Table 100. Eton Bioscience DNA Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Eton Bioscience DNA Synthesis Service Product Portfolio Table 102. Eton Bioscience Recent Development Table 103. Synbio Technologies Company Information Table 104. Synbio Technologies Business Overview Table 105. Synbio Technologies DNA Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Synbio Technologies DNA Synthesis Service Product Portfolio Table 107. Synbio Technologies Recent Development Table 108. Eurogentec Company Information Table 109. Eurogentec Business Overview Table 110. Eurogentec DNA Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Eurogentec DNA Synthesis Service Product Portfolio Table 112. Eurogentec Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. DNA Synthesis Service Product Image Figure 2. Global DNA Synthesis Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Synthesis Service Market Size (2021-2032) & (US$ Million) Figure 4. Global DNA Synthesis Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oligonucleotide Synthesis Image Figure 8. Gene Synthesis Image Figure 9. Global DNA Synthesis Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global DNA Synthesis Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global DNA Synthesis Service Sales Value Share by Type (2021-2032) Figure 12. Commercial Image Figure 13. Academic Research Image Figure 14. Global DNA Synthesis Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global DNA Synthesis Service Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global DNA Synthesis Service Sales Value Share by Application (2021-2032) Figure 17. Global DNA Synthesis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global DNA Synthesis Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America DNA Synthesis Service Sales Value (2021-2032) & (US$ Million) Figure 20. North America DNA Synthesis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe DNA Synthesis Service Sales Value (2021-2032) & (US$ Million) Figure 22. Europe DNA Synthesis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific DNA Synthesis Service Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific DNA Synthesis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America DNA Synthesis Service Sales Value (2021-2032) & (US$ Million) Figure 26. South America DNA Synthesis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa DNA Synthesis Service Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa DNA Synthesis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt DNA Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Oligonucleotide Synthesis
  • Gene Synthesis
Applications
  • Commercial
  • Academic Research
Companies covered
  • Genescript
  • Thermo Fisher Scientific
  • IDT
  • Eurofins Genomics
  • DNA 2.0 (ATUM)
  • BBI
  • Azenta Life Sciences
  • SBS Genetech
  • Bio Basic
  • Twist Bioscience
  • OriGene
  • Bioneer
  • Eton Bioscience
  • Synbio Technologies
  • Eurogentec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DNA Synthesis Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DNA Synthesis Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 DNA Synthesis Service Market Dynamics
  1. 2.1 DNA Synthesis Service Industry Trends
  2. 2.2 DNA Synthesis Service Industry Drivers
  3. 2.3 DNA Synthesis Service Industry Opportunities and Challenges
  4. 2.4 DNA Synthesis Service Industry Restraints
3 DNA Synthesis Service Market by Company
  1. 3.1 Global DNA Synthesis Service Company Revenue Ranking in 2025
  2. 3.2 Global DNA Synthesis Service Revenue by Company (2021-2026)
  3. 3.3 Global DNA Synthesis Service Company Ranking (2024-2026)
  4. 3.4 Global DNA Synthesis Service Company Manufacturing Base and Headquarters
  5. 3.5 Global DNA Synthesis Service Company Product Type and Application
  6. 3.6 Global DNA Synthesis Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global DNA Synthesis Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 DNA Synthesis Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 DNA Synthesis Service Market by Type
  1. 4.1 DNA Synthesis Service Type Introduction
  2. 4.1.1 Oligonucleotide Synthesis
  3. 4.1.2 Gene Synthesis
  4. 4.2 Global DNA Synthesis Service Sales Value by Type
  5. 4.2.1 Global DNA Synthesis Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global DNA Synthesis Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global DNA Synthesis Service Sales Value Share by Type (2021-2032)
5 DNA Synthesis Service Market by Application
  1. 5.1 DNA Synthesis Service Application Introduction
  2. 5.1.1 Commercial
  3. 5.1.2 Academic Research
  4. 5.2 Global DNA Synthesis Service Sales Value by Application
  5. 5.2.1 Global DNA Synthesis Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global DNA Synthesis Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global DNA Synthesis Service Sales Value Share by Application (2021-2032)
6 DNA Synthesis Service Regional Value Analysis
  1. 6.1 Global DNA Synthesis Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA Synthesis Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global DNA Synthesis Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global DNA Synthesis Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DNA Synthesis Service Sales Value (2021-2032)
  7. 6.3.2 North America DNA Synthesis Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe DNA Synthesis Service Sales Value (2021-2032)
  10. 6.4.2 Europe DNA Synthesis Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific DNA Synthesis Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific DNA Synthesis Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America DNA Synthesis Service Sales Value (2021-2032)
  16. 6.6.2 South America DNA Synthesis Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa DNA Synthesis Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa DNA Synthesis Service Sales Value Share by Country, 2025 VS 2032
7 DNA Synthesis Service Country-level Value Analysis
  1. 7.1 Global DNA Synthesis Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DNA Synthesis Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global DNA Synthesis Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global DNA Synthesis Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt DNA Synthesis Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt DNA Synthesis Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt DNA Synthesis Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Genescript
  2. 8.1.1 Genescript Company Information
  3. 8.1.2 Genescript Business Overview
  4. 8.1.3 Genescript DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Genescript DNA Synthesis Service Product Portfolio
  6. 8.1.5 Genescript Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific DNA Synthesis Service Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 IDT
  14. 8.3.1 IDT Company Information
  15. 8.3.2 IDT Business Overview
  16. 8.3.3 IDT DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 IDT DNA Synthesis Service Product Portfolio
  18. 8.3.5 IDT Recent Developments
  19. 8.4 Eurofins Genomics
  20. 8.4.1 Eurofins Genomics Company Information
  21. 8.4.2 Eurofins Genomics Business Overview
  22. 8.4.3 Eurofins Genomics DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eurofins Genomics DNA Synthesis Service Product Portfolio
  24. 8.4.5 Eurofins Genomics Recent Developments
  25. 8.5 DNA 2.0 (ATUM)
  26. 8.5.1 DNA 2.0 (ATUM) Company Information
  27. 8.5.2 DNA 2.0 (ATUM) Business Overview
  28. 8.5.3 DNA 2.0 (ATUM) DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DNA 2.0 (ATUM) DNA Synthesis Service Product Portfolio
  30. 8.5.5 DNA 2.0 (ATUM) Recent Developments
  31. 8.6 BBI
  32. 8.6.1 BBI Company Information
  33. 8.6.2 BBI Business Overview
  34. 8.6.3 BBI DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BBI DNA Synthesis Service Product Portfolio
  36. 8.6.5 BBI Recent Developments
  37. 8.7 Azenta Life Sciences
  38. 8.7.1 Azenta Life Sciences Company Information
  39. 8.7.2 Azenta Life Sciences Business Overview
  40. 8.7.3 Azenta Life Sciences DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Azenta Life Sciences DNA Synthesis Service Product Portfolio
  42. 8.7.5 Azenta Life Sciences Recent Developments
  43. 8.8 SBS Genetech
  44. 8.8.1 SBS Genetech Company Information
  45. 8.8.2 SBS Genetech Business Overview
  46. 8.8.3 SBS Genetech DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SBS Genetech DNA Synthesis Service Product Portfolio
  48. 8.8.5 SBS Genetech Recent Developments
  49. 8.9 Bio Basic
  50. 8.9.1 Bio Basic Company Information
  51. 8.9.2 Bio Basic Business Overview
  52. 8.9.3 Bio Basic DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bio Basic DNA Synthesis Service Product Portfolio
  54. 8.9.5 Bio Basic Recent Developments
  55. 8.10 Twist Bioscience
  56. 8.10.1 Twist Bioscience Company Information
  57. 8.10.2 Twist Bioscience Business Overview
  58. 8.10.3 Twist Bioscience DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Twist Bioscience DNA Synthesis Service Product Portfolio
  60. 8.10.5 Twist Bioscience Recent Developments
  61. 8.11 OriGene
  62. 8.11.1 OriGene Company Information
  63. 8.11.2 OriGene Business Overview
  64. 8.11.3 OriGene DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 OriGene DNA Synthesis Service Product Portfolio
  66. 8.11.5 OriGene Recent Developments
  67. 8.12 Bioneer
  68. 8.12.1 Bioneer Company Information
  69. 8.12.2 Bioneer Business Overview
  70. 8.12.3 Bioneer DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bioneer DNA Synthesis Service Product Portfolio
  72. 8.12.5 Bioneer Recent Developments
  73. 8.13 Eton Bioscience
  74. 8.13.1 Eton Bioscience Company Information
  75. 8.13.2 Eton Bioscience Business Overview
  76. 8.13.3 Eton Bioscience DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Eton Bioscience DNA Synthesis Service Product Portfolio
  78. 8.13.5 Eton Bioscience Recent Developments
  79. 8.14 Synbio Technologies
  80. 8.14.1 Synbio Technologies Company Information
  81. 8.14.2 Synbio Technologies Business Overview
  82. 8.14.3 Synbio Technologies DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Synbio Technologies DNA Synthesis Service Product Portfolio
  84. 8.14.5 Synbio Technologies Recent Developments
  85. 8.15 Eurogentec
  86. 8.15.1 Eurogentec Company Information
  87. 8.15.2 Eurogentec Business Overview
  88. 8.15.3 Eurogentec DNA Synthesis Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Eurogentec DNA Synthesis Service Product Portfolio
  90. 8.15.5 Eurogentec Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research